REQUEST A DEMO
Total
USD $0.00
Search more companies

Susaah Laboratories Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Susaah Laboratories Private Limited Profile Updated: June 10, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Susaah Laboratories Private Limited is an unlisted company, incorporated on 23/08/2007. It has its registered office in the State of Telangana, India. Company's corporate identification number (CIN) is U24232TG2007PTC055239 and registration number is 055239. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Headquarters
Flat No. 202 Shashank Residency Opp: Radhika Theatre Ecil Kapra Secunderabad Hyderabad In 500062
Hyderabad; Telangana; Postal Code: 500062

Contact Details: Purchase the Susaah Laboratories Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Susaah Laboratories Private Limited report to view the information.
Registered Capital:
Purchase the Susaah Laboratories Private Limited report to view the information.
Incorporation Date:
August 23, 2007
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
68.97%
Purchase this report to view the information.
0.01%
Company Performance
Financial values in the chart are available after Susaah Laboratories Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
86.11%
Total operating revenue
85.97%
Operating profit (EBIT)
57.62%
EBITDA
31.53%
Net Profit (Loss) for the Period
70.99%
Total assets
37.53%
Total equity
45.02%
Operating Profit Margin (ROS)
-0.76%
Net Profit Margin
-0.27%
Return on Equity (ROE)
0.52%
Debt to Equity Ratio
-22.05%
Quick Ratio
0.25%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?